The main risk is not whether MACOM has attractive markets; it is whether shipment conversion, fab leverage and program timing arrive fast enough to justify a
premium multiple already near peak levels. If
1.6T and 3.2T ramps pause, customers multi-source more aggressively, or defense-space programs slip, the business can still grow while equity returns disappoint.